Journal of the Neurological Sciences
Volume 291, Issue 1 , Pages 12-16 , 15 April 2010

The effect of dopamine agonists: The expression of GDNF, NGF, and BDNF in cultured mouse astrocytes

  • Kiyoe Ohta

      Affiliations

    • Clinical Research Center, National Hospital Organization, Utano National Hospital, Kyoto 616-8255, Japan
    • Corresponding Author InformationCorresponding author. Department of Medical Biochemistry, Kobe Pharmaceutical University, 4-19-1 Motoyama-kita-machi, Higashinada-ku, Kobe, 658-8558, Japan. Tel.: +81 78 441 7557; fax: +81 78 441 7559.
    • ,
  • Sadako Kuno

      Affiliations

    • National Center Hospital of Neurology and Psychiatry, Kodaira city, Tokyo 187-8551 Japan
    • ,
  • Seiji Inoue

      Affiliations

    • Department of Biochemistry, Osaka University of Pharmaceutical Sciences, Takatsuki, Osaka 569-1094, Japan
    • ,
  • Erika Ikeda

      Affiliations

    • Department of Medical Biochemistry , Kobe Pharmaceutical University, Kobe 658-8558, Japan
    • ,
  • Aya Fujinami

      Affiliations

    • Department of Medical Biochemistry , Kobe Pharmaceutical University, Kobe 658-8558, Japan
    • ,
  • Mitsuhiro Ohta

      Affiliations

    • Clinical Research Center, National Hospital Organization, Utano National Hospital, Kyoto 616-8255, Japan
    • Department of Medical Biochemistry , Kobe Pharmaceutical University, Kobe 658-8558, Japan

Received 17 September 2008 ,Revised 10 January 2010 ,Accepted 14 January 2010.

References 

  1. Mattson MP. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol. 2000;1:120–129
  2. Mufson EJ, Kroin JS, Sendera TJ, Sobreviela T. Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases. Prog Neurobiol. 1999;57:451–484
  3. Hoffer BJ, Hoffman A, Bowenkamp K, Huettl P, Hudson J, Martin D, et al. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci Lett. 1994;182:107–111
  4. Gash DM, Zhang Z, Ovadia A, Cass WA, Yi A, Simmerman L, et al. Functional recovery in parkinsonian monkeys treated with GDNF. Nature. 1996;380:252–255
  5. Tomac A, Lindqvist E, Lin LFH, Ögren SO, Young D, Hoffer BJ, et al. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 1995;373:335–339
  6. Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L, et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science. 2000;290:767–773
  7. Kearns CM, Gash DM. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 1995;672:104–111
  8. Ugarte SD, Lin E, Klann E, Zigmond MJ, Perez RG. Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK. J Neurosci Res. 2003;73:105–112
  9. Kordower JH, Palfi S, Chen EY, Ma SY, Sendera T, Cochran EJ, et al. Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease. Ann Neurol. 1999;46:419–424
  10. Ohta K, Kuno S, Mizuta I, Fujinami A, Matsui H, Ohta M. Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes. Life Sci. 2003;73:617–626
  11. Ohta M, Mizuta I, Ohta K, Nishimura M, Mizuta E, Hayashi K, et al. Apomorphine up-regulates NGF and GDNF synthesis in cultured mouse astrocytes. Biochem Biophys Res Commun. 2000;272:18–22
  12. Höglinger GU, Rizk P, Muriel MP, Duyckaerts C, Oertel WH, Caille I, et al. Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neurosci. 2004;7:726–735
  13. Hofer M, Pagliusi SR, Hohn A, Leibrock J, Barde YA. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J. 1990;9:2459–2464
  14. Watabe K, Fukuda T, Tanaka J, Honda H, Toyohara K, Sakai O. Spontaneously immortalized adult mouse Schwann cells secrete autocrine and paracrine growth-promoting activities. J Neurosci Res. 1995;41:279–290
  15. Nakajima K, Hida H, Shimano Y, Fujimoto I, Hashitani T, Kumazaki M, et al. GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons. Brain Res. 2001;916:76–84
  16. Bozzi Y, Borrelli E. Dopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do with it?. Trends Neurosci. 2006;29:167–174
  17. Yan Y, Yamada K, Niwa M, Nagai T, Nitta A, Nabeshima T. Enduring vulnerability to reinstatement of methamphetamine-seeking behavior in glial cell line-derived neurotrophic factor mutant mice. FASEB J. 2007;21:1994–2004
  18. Camicella S, Kharazia V, Jeanblanc J, Janak PH, Ron D. GDNF is a fast-acting potent inhibitor of alcohol consumption and replace. Proc Natl Acad Sci. 2008;105:8114–8119
  19. Green-Sadan T, Kuttner Y, Lublin-Tennenbaum T, Kinor N, Boguslavsky Y, Mangel S, et al. Glial cell line-derived neurotrophic factor-conjugated nanoparticles suppress acquisition of cocaine self-administration in rats. Exp Neurol. 2005;194:97–105
  20. Kinor N, Geffen R, Golomb E, Zinman T, Yadid G. Dopamine increases glial cell line-derived neurotrophic factor in human fetal astrocytes. Glia. 2001;33:143–150
  21. Du F, Li R, Huang Y, Li X, Le W. Dopamine D3 receptor-preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons. Eur J Neurosci. 2005;22:2422–2430
  22. Ling ZD, Tong CW, Carvey PM. Partial purification of a pramipexole-induced trophic activity directed at dopamine neurons in ventral mesencephalic cultures. Brain Res. 1998;791:137–145
  23. Coldwell MC, Boyfield I, Brown T, Hagan JJ, Middlemiss DN. Comparison of the functional potencies of ropinirole and other dopamine receptor agonists at human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells. Br J Pharmacol. 1999;127:1696–1702
  24. Miklic S, Juric DM, Carman-Krzan M. Differences in the regulation of BDNF and NGF synthesis in cultured neonatal rat astrocytes. Int J Dev Neurosci. 2004;22:119–130
  25. Zafra F, Lindholm D, Castren E, Hartikka J, Thoenen H. Regulation of brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurons and astrocytes. J Neurosci. 1992;12:4793–4799
  26. Nagatsu T, Mogi M, Ichinose H, Togari A. Changes in cytokines and neurotrophines in Parkinson's disease. J Neural Transm. 2000;7:277–290
  27. Nishio T, Furukawa S, Akiguchi I, Sunohara N. Medial nigral dopamine neurons have rich neurotrophin support in humans. NeuroReport. 1999;9:2847–2851
  28. Parain K, Murer MG, Yan Q, Faucheux B, Agid Y, Hirsch E, et al. Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra. NeuroReport. 1999;10:557–561

PII: S0022-510X(10)00039-0

doi: 10.1016/j.jns.2010.01.013

Journal of the Neurological Sciences
Volume 291, Issue 1 , Pages 12-16 , 15 April 2010

Article Tools

* Image Usage & Resolution